In May 2021, the US Preventive Services Task Force (USPSTF) revised the colorectal cancer (CRC) screening age for average-risk adults to 45 years. However, stakeholders are concerned about the lack of awareness, access, and motivation among the younger age group to get screened. Now, a new research study has found that the prevalence of CRC screening remained lowest for individuals ages 50 to 54 years old and young adults (age<50) experienced smaller increases in screening prevalence over time, regardless of race, ethnicity, education, income, and insurance coverage. 

An investigation using population-based data from the National Health Interview Survey (NHIS), an annual, cross-sectional survey of the U.S. population conducted by the National Center for Health Statistics at the U.S. Centers for Disease Control and Prevention, studied CRC screening participation using surveys from multiple years. A sample of 80,220 participants ages 50 to 75 years old was analyzed for CRC screening participation. For each survey year, the prevalence of CRC screening was estimated for age, race, ethnicity, educational attainment, family income, and health insurance.

Racial, ethnic, and socioeconomic disparities influence screening rates. Despite the prevalence of CRC screening increasing from 36.7% in 2000 to 66.1% in 2018, screening prevalence was observed to be the lowest for:

  • Participants ages 50 to 54 years old
  • Hispanic populations (56.5%)
  • Asian populations (57.1%)
  • Participants with less than a high school degree (53.6%)
  • Participants from low-income families (56.6%)
  • Participants without insurance (39.7%) 

This may be the result of a lack of concern for cancer and cancer screening among younger adults and their healthcare providers, limited access to healthcare, absence of or limited insurance coverage, and other priorities for young adults, such as work and family. Disparities in screening rates can potentially extend to adults ages 45 to 49 as the new USPSTF recommendations are implemented. Multilevel barriers, such as patient-, provider-, and system-level factors, impact the completion of CRC screening for young adults (age<50), creating disparities and inequities in CRC screening. The administration of new CRC screening guidelines must acknowledge and account for multilevel disparities in screening programs to ensure all populations have equal access to CRC screening and benefit from CRC screening, especially newly eligible adults ages 45 to 49 years old. 

The benefits and outcomes of the updated USPSTF guidelines to extend CRC screening to ages 45 to 49 years old have been debated by clinicians and researchers. Concerns about the updated guidelines include redirecting endoscopic resources away from higher-risk and older patients, resulting in a more significant exacerbation of health disparities. Another criticism is that adults ages 45 to 49 years old who participate in screening may be less likely to belong to groups at higher CRC risk. 

One benefit of expanding CRC screening to the 45-49 age group is to increase the screening participation rate among older populations. Awareness of CRC screening may also increase, resulting in newly eligible adults having more time to schedule their first screening test. However, the impact of screening among those in the 45-49 age group on disparities, benefits, and participation of older adults may take several years to be fully recognized and understood, as the USPSTF’s effect on insurance coverage only occur in mid-2022.

Sahar Alam is a Colon Cancer Prevention Intern with the Colon Cancer Foundation.

Jamie Crespo lives in Seattle, Washington and is a Colon Cancer Foundation (CCF) Champion. She was introduced to CCF through the New York City marathon when she registered to run for our charity in 2020. When looking through charities, she found that CCF’s mission and cause was relevant to her personal experience with her family. Due to the COVID-19 pandemic, she ran the marathon in 2021.

In 2017, Jamie’s parents who were both in their 60s had never undergone a screening colonoscopy. In the absence of a family history of colon cancer, they did not even consider scheduling one. However, her father started losing a significant amount of weight and seemed very pale. When Jamie persuaded him to see a doctor, they discovered he had internal bleeding. After running some tests, the doctors found a mass in his colon. Following a colectomy, he was diagnosed with stage 3B colon cancer. Jamie’s father started chemotherapy in the fall of 2017 and is, fortunately, in remission!

In the beginning of the same year, Jamie’s mother was to receive a check-up but it was delayed to the fall due to her father’s diagnosis and subsequent treatment. Unfortunately, when her mother went through a screening colonoscopy, she was diagnosed with stage 1 colon cancer. Thankfully, she was able to undergo a laparoscopic colectomy, in time, and remains in remission.

With no known history of colon cancer in her family, Jamie emphasizes that everyone should initiate their screening at the recommended age of 45 years. She promotes preventative care knowing that typically, individuals who present with symptoms may be diagnosed at a more advanced stage when the disease is less treatable. Ever since her parents’ diagnoses, Jamie posts regularly on social media and raises money for the CCF. She is a member of the Club Seattle Runners Division and posted photos of her run to promote colorectal cancer awareness as well as relay her personal story of colorectal cancer. 

You can find Jamie on Instagram: @jamielynette

Kenadi Kaewmanaprasert is a Colon Cancer Prevention Intern with the Colon Cancer Foundation. 

The American Gastroenterological Association (AGA) has developed 8 position statementssolutions to eliminate colorectal cancer (CRC) screening barriers and reduce CRC burden. Evidence supports the existence of disparities in CRC screening: individuals with low income and lack of access to insurance coverage are disproportionately affected. Cost-sharing for preventive screening, in the form of deductibles and copayments, can be a financial barrier for some individuals. CRC screening programs and policies should cover all the steps following screening because each element is essential to the effectiveness of a screening program. Furthermore, these factors should not be subject to cost-sharing. Uniform, equitable delivery of screening programs will not only improve adherence and participation in CRC screening but also eliminate health disparities and reduce the burden of CRC in the United States. 

The following infographic details AGA’s approach:

The position statements have been published in Gastroenterology.

 

Photo credit: Clarissa Watson on Unsplash

Sahar Alam is a Colorectal Cancer Prevention Intern at the Colon Cancer Foundation.

Justin Adler is a Colon Cancer Foundation (CCF) Champion who lives in New York City. He works for a small SaaS (Software as a Service) company leading their strategic finance team. In addition to being involved with CCF, Justin coaches a football team and is a member of the Big Brothers Big Sisters of New York where he mentors a 9-year-old boy. He joined CCF in the beginning of 2022 as he hoped to be involved with something more personal.

CCF Champions started off as a young leadership council of the board—it has now evolved into a team of individuals with a personal or familial impact of colorectal cancer. The team meets on a monthly basis to discuss how best to support CCF’s mission of raising awareness around colorectal cancer from a board perspective, including leading and participating in the Foundation’s events.

One such event was  the annual Colon Cancer Challenge 5K Run/Walk during the Colorectal Cancer Awareness Month in March. Each Champion led their own team and fundraised individually. As a team, they also create social media campaigns. Recently, they partnered with DuClaw Brewing on their “Give A Crap” campaign to fundraise and share each champion’s personal story around colorectal cancer.

Justin was 8 years old when his mother passed away from colon cancer. Seeing at a young age how the disease affected his mom and their family, he is very keen to spread the word on the importance of early detection. Because his mother was not screened prior to her diagnosis, his main goal is to push the message of colorectal cancer screening. Justin notices that individuals without a family history of colorectal cancer are not as motivated to schedule a colonoscopy. They sometimes push it off until they are required to receive one, which could potentially be deadly for some. He emphasizes building a level of comfort around the topic, citing the “Give A Crap” challenge as an example, where they spoke openly about the elephant in the room.

Justin and the rest of the CCF Champions are always on a lookout for opportunities to partner with and help further colorectal cancer research and treatment through fundraisers and also spreading awareness.

 

Kenadi Kaewmanaprasert  is a Colon Cancer Prevention Intern with the Colon Cancer Foundation.

With an observed increase of distant-stage colorectal cancer (CRC) among young patients in recent years, researchers have been searching for the reasons behind rising numbers and ways to counteract them. Carcinoids, a subtype of slow-growing cancer, have been found to contribute to the steadily rising incidence rate of early-onset colorectal cancer, which is diagnosed before the age of 50. This has created a need to assess the shifts toward distant-stage adenocarcinoma and its impact on public health.

Why Are We Seeing This Increase?

A study recently published in Cancer Epidemiology, Biomarkers & Prevention sought to understand how the proportions of distant-stage disease changed over time. Several studies have identified a significant increase (49%) in the average annual percent change for distant stage colorectal cancer in the 20-34 years age group. However, many of these studies do not report histological subtypes of CRC. 

With carcinoids increasing in younger patients, it is important to look at adenocarcinoma (most common cancer of the colon and rectum) staging independently from carcinoids (neuroendocrine tumors). Therefore, these researchers focused specifically on adenocarcinomas. Yearly adenocarcinoma incidence rates from the 2000-2016 Surveillance Epidemiology And End Results (SEER) data were stratified by stage, age, subsite, and race for 103,975 patients. Changes in the three-year annual incidence rate were calculated with the percent contribution of each cancer stage. Lastly, the subgroup with the highest proportion of distant-stage disease was determined.

The greatest percent increases were seen in distant-stage cancer when comparing data from 2000-2002 with 2014-2016. Here are a few significant findings of the study:

  • Colon-only distant adenocarcinoma increased most in 30-39-year-olds (49%)
  • Rectal-only distant-stage adenocarcinoma increased most in 20-29-year-olds (133%)
  • Based on race:
    • Distant stage proportions increased most for both colon- and rectal-only subsites in 20-29-year-old non-Hispanic Blacks (14% and 46%, respectively) 
    • The second most-impacted group was 20-29-year-old Hispanics with a 13% increase in the proportion of those affected by rectal-only, distant stage adenocarcinoma.

From these findings, we can conclude that the greatest burden of disease was on younger patients, highest in the non-Hispanic Black and Hispanic subgroups (despite relatively low absolute case counts). The researchers also uncovered that there is a decrease in early-stage disease in these early-onset groups. As we now know, younger patients are presented with higher risks, but the absolute incidence rates in the youngest subgroups remain relatively low.

These findings are important because they set a new precedent for patients under 50 who may not be aware that preventive screening for those at average risk of CRC starts at 45 years. Studies moving forward should also note that not all adenocarcinomas are categorized as early-onset CRC. Although this study is limited in its observational nature, it raises important questions in analyzing staging results, promoting screening opportunities, and keeping the general public aware of their risks. This study also presents potential solutions, including optimizing earlier screening and the risk-stratification of younger patients by family history and symptoms.

 

Juhi Patel is  Colon Cancer Prevention Intern.

Mom, wife, realtor, runner, cellist, and colon cancer survivor for five and a half years. Suzanne Miller was taken aback when she was diagnosed with Stage I colon cancer at the age of 40. Colorectal cancer screenings start at 45 years for average-risk adults. She was in good health, trained for marathons, and ate well. Luckily, she was able to undergo surgery on November 18, 2016, to remove the cancer. 

Suzanne realized she aspired to turn this event in her life into something good rather than dwelling on the fact that she had cancer. Since her surgery, on the 18th of each month, she spreads awareness by posting on Instagram and Facebook to remind individuals to “keep their rear in the clear.” Everyone who is over 45, under 45 with symptoms, or has a family history of colon or rectal cancer should get screened for colorectal cancer. Those with a family history of colorectal cancer should start screenings at 40 years or 10 years prior to the earliest diagnosis age in their family.

Survivor and Colon Cancer Awareness Advocate

Suzanne came across the Colon Cancer Foundation (CCF) while she was researching for a marathon to run in New York while raising money for a charity. She reached out to the Foundation and planned to run in the 2020 marathon, but it was canceled due to the COVID-19 pandemic. That didn’t dampen Suzanne’s spirit. She completed the marathon in her hometown and raised the money with support from her friends and family members who participated in the run. She looks forward to running again in the 2023 Colon Cancer Challenge.

This past February, as a CCF Champion, Suzanne and her husband were invited to attend the Cologuard Classic in Tucson, Arizona. She represented CCF and was able to meet 90 other like-minded individuals who shared her passion to make a difference and prevent early onset of colon cancer. Inspired to raise money and awareness in her hometown, Suzanne partnered with her husband’s golf club to hold a fundraising golf tournament on May 16, 2022. She was supported in her efforts by her friend, a 10-year colon cancer survivor who also works to spread colorectal cancer awareness. The event had 10 sponsors, 13 teams, and 20 hole sponsors that covered most of the costs. Half of the profits will go to their local nonprofit, CRC Life, and the other half will go to CCF.

Suzanne emphasizes that people need to be more comfortable discussing colon cancer, as they do other topics. Ever since she began raising awareness on social media, Suzanne has received messages from individuals when they received a colonoscopy, got a polyp removed, or discovered they have a family history of colon cancer. Through her experience as a young, healthy woman diagnosed with colon cancer, she brings attention to the fact that cancer does not discriminate. She always tells individuals to remind their friends and family to get a colonoscopy. “Even having one person find out that they do not have cancer is a win,” she says. Suzanne loves that we live in a world where we can speak our mind, while being kind and courteous, and have people that listen and don’t discount the matter at hand. 

 

Kenadi Kaewmanaprasert is an intern with the Colon Cancer Foundation.

“This is a problem with a solution. The solution is awareness of the colorectal cancer problem and getting screened.”
– Dr. Thomas K. Weber, Founder, Colon Cancer Foundation

My late father Dr. Thomas Weber founded the Colon Cancer Foundation (CCF) because he recognized the power of preventing colorectal cancer and diagnosing it early through screenings. The screenings identify precancerous polyps and early stage growths that doctors can remove.

The CCF has now led the mission of raising awareness and increasing screenings for 19 years.

As we enter Colorectal Cancer Awareness Month in March, you can take direct action today to solve the colorectal cancer problem and save lives:

Talk to your doctor about getting a colonoscopy if you are 45 years or older. If you are younger than 45 but have one or more family members that were diagnosed with colorectal cancer, ask your doctor if you should start screening earlier.

Participate and help increase visibility for CCF’s awareness campaigns and fund colorectal cancer screenings.

Donate Now: The funds collected through your fundraising efforts enable us to reach more people with life saving public awareness, prevention, and research programs.

Two Reasons to Show Your Support

Reason #1: Screenings were down due to COVID-19 but are beginning to pick up again. That’s great news, but it is critical that colonoscopy rates grow past pre-pandemic levels to save lives.

Reason #2:  Deaths from colorectal cancer in people ages 0-49 are increasing. Educating our friends and family with high risk factors can help identify and treat the disease in young people.

CCF’s March Awareness events, tools, and resources are designed to maximize the impact of your donations.

Thank you for taking action!

Sincerely,

Nick Weber

P.S. Your support, plus our ongoing work to mobilize the medical community to address colorectal cancer in young people with the Early-Age Onset Colorectal Cancer Summit, will make a difference!

In 2013, The Bourbon Mafia was formed when a group of bourbon enthusiasts and industry professionals came together in their search for rare bourbon. About a year in, they realized that they could utilize their platform to raise money for causes that are near and dear to their hearts. With 42 members spanning 11 U.S. states, and two members in Australia, the organization has raised approximately $150,000 since 2014  for various charities, including the Colon Cancer Foundation (CCF). The Bourbon Mafia raises money through events, including bourbon raffles, dinners, and bottle auctions.

Brian Gelfo, one of the founding members and the  treasurer and secretary of the Bourbon Mafia, spoke with the Colon Cancer Foundation about their organization’s motivation for donating to CCF. Omar Marshall was one of the first classes brought into The Bourbon Mafia. Following his diagnosis of colorectal cancer (CRC) in 2020, he and his wife, Pam Marshall, decided they wanted to raise awareness around this disease. The initial goal of The Bourbon Mafia was to donate in his honor while Omar was still with them. Unfortunately, Omar lost his battle with CRC on January 18, 2021.

Robert Diaz (second from left) receiving a donation from The Bourbon Mafia on behalf of the Colon Cancer Foundation.

Nevertheless, a $30,000 donation was made to CCF in April 2021. Before Omar passed, he participated in a selection of a Four Roses Bourbon barrel that would be used for the donation. Mr. Gelfo highlighted an impactful statement by Robert Diaz who represented CCF at the engagement event: “This $30,000 donation can fund 1,000 colon cancer screenings.” Members of The Bourbon Mafia were gratified that their efforts could impact the lives of a thousand people. “Even if one finds out early and gets treated, it’s well worth it,” Mr. Gelfo said. 

According to Mr. Gelfo, many members in the bourbon industry, including fans and supporters, are predominantly older men. Through these events, The Bourbon Mafia hopes to raise awareness in the community for them to get screened.

This year, their event was held on 25th February, 2022, in Louisville, Kentucky, where they expected to raise a minimum of $10,000. Barrels will be hand selected from Starlight Distillery and guests will receive a sample of bourbon, a beer, and a bottle of bourbon to take home. Silent auction items will be donated by Mrs. Marshall and the family as well as other distilleries.

Mr. Marshall was buried on the farm under an oak tree from where he can watch over the farm, as he always wanted to. Mrs. Marshall emphasized the importance of early detection and being proactive for any type of cancer. “The Bourbon Mafia and bourbon itself has brought me into contact with so many wonderful people who share the same passion for bourbon and helping others,” she said.

 

Kenadi Kaewmanaprasert is an intern with the Colon Cancer Foundation.

Will Holman is a writer-producer and is the founder of the post-production company Super Star Power Productions. Having lost his dad Willie Holman, and his friend, actor Chadwick Boseman, to colorectal cancer (CRC), Will was inspired to create a non-fungible token (NFT) series in their honor that will be auctioned online starting January 10th, and proceeds from the auction will be donated to charitable causes, including the Colon Cancer Foundation  (CCF). “I wanted to honor Chadwick’s legacy and also give back to the community,” Will told the CCF in an interview.

At 46 years, Will is very aware of his personal risk for CRC. His father, Willie Holman, a football player—defensive lineman for the Chicago Bears—was diagnosed with and died from colon cancer in 2002 at age 57. His family, however, was unaware of his diagnosis. Consequently, Will has started screening himself early. He first got tested at 41 years—the recommendation is to start screening at age 40 or 10 years before your first-degree relative was diagnosed with CRC. The USPSTF recommends that all average-risk adults should initiate screening at 45 years. He is also very conscious of his dietary habits and the important connection between eating healthy and preventive wellness.

Willie Holman was from South Carolina. “A country boy who used to work out a lot but did not know much about health and wellness and what it was to take care of himself,” Will said describing his father’s lifestyle. Being aware of the lineage he carries, Will does not want himself or his children going down that same path. “My father’s experience has a big influence on my healthy lifestyle.”

The risk of colon cancer “is not talked about and dealt with, especially in the black community,” he said.  Will is also aware of the lack of access to healthy food for those living in low-income neighborhoods. Many of these neighborhoods are identified as “food deserts”: the residents in these areas lack access to supermarkets or food vendors that sell affordable yet nutritious food such as fresh fruits and vegetables. If the residents do not have easy access to transportation, they may not be able to reach supermarkets that sell fresh food and may have to depend on their corner grocery store that sells processed foods that may not be healthy. Research has shown that survival is worse among colorectal cancer patients living in food deserts.

By paying homage to both his father and to Boseman through his digital art pieces, Will hopes to give back to the community via his charitable contribution to CCF.

The NFT collection is available on Opensea and the individual links are below:

OpenSea_1

OpenSea_2

OpenSea_3

OpenSea_4

OpenSea_5

OpenSea_6

OpenSea_7

OpenSea_8

OpenSea_9

A study conducted by researchers in Japan found that cigarette smoking may increase the risk of colorectal cancer (CRC) incidence in a Japanese population While smoking has been associated with an increased risk of CRC among Western populations, it has not been investigated as a risk factor in Asian populations prior to this study, according to the authors.

 

Statistics show that 60% of CRC cases occur in developed countries and CRC incidence continues to increase rapidly in Asia. Specifically, Japan experienced an increase in cases from 1978 to 1993 and has remained stable since then but is still among the top 10 countries with the highest incidence of CRC. A separate Japanese study found a gender-based difference in CRC incidence, with men being more susceptible to rectal cancer and women being more susceptible to colon cancer:

 

Colon cancer:

  • Men: 65.7%
  • Women: 75.4%

Rectal cancer:

  • Men: 34.3%
  • Women: 27.0%

 

It is hypothesized that environmental and lifestyle factors, such as smoking, can increase the risk of CRC. In Japan, for instance, 80% of men and 20% of women were smokers in the 1950s. However, a significant reduction was observed in smoking rates by 2017: only 32% of men and 9% of women were smokers. The age-standardized CRC incidence rate was 22.2 in 1978 and 38.9 in 2018.

 

Tobacco use can cause many different cancers, including mouth, larynx, lung, kidney, liver, and many more . In 2014, the U.S. Surgeon General’s report added CRC to the list of tobacco-related cancers. However, there are some issues with this:

  • Evidence supporting the claim that the use of tobacco is associated with the development of colon cancer has been derived mainly from Western populations while data from Asian populations are conflicting. More research is needed on this association in Asian populations.
  • Meta-analysis by geographic region did not find a significant association between smoking and CRC in Asian studies

The Japanese study aimed to investigate the correlation of smoking and CRC incidence in Asian populations.

 

Researchers used original data from major cohort studies performed by the Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan. The following criteria  were used when examining these studies for this analysis:

 

  • Population-based cohort studies conducted in Japan
  • Studies initiated between the mid-1980s and mid-1990s
  • Studies with more than 30,000 participants
  • Studies that acquired information on health-related lifestyles
  • Studies that followed the incidence of CRC

 

A self-administered questionnaire at the baseline survey determined if each participant was a smoker and classified them into one of three groups: never smoker, former smoker, or current smoker. Participants were followed-up for CRC incidence from the baseline study until the date of CRC diagnosis, migration out of the study area, death or the end of follow-up, whichever was first. The end of the follow-up period was between December 31, 1992 and December 31, 2014.

 

The study found that men who were ever, current or former smokers had a statistically significant higher risk of CRC than never smokers. Ever and current smoking increased the risk of both colon and rectal cancer, while former smokers had an increased risk of colon cancer.

Women who were ever, current or former smokers did not have an increased risk of CRC, but a significantly greater risk of distal colon cancer. Women who were heavily exposed to smoking had an increased risk of CRC.

 

Colon cancer is one of the most preventable diseases through screening methods and avoiding risk factors such as smoking , obesity, and poor diet. The American Cancer Society recommends getting screened at age 45 or younger if you have a family history of CRC.